UiPath holder proposes $32.7M common share sale
UiPath had 456,464,703 shares outstanding, the share-count figure reported alongside ICEVULCAN INVESTMENTS LIMITED’s planned sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UiPath, Inc. (PATH) is the issuer for ICEVULCAN INVESTMENTS LIMITED’s proposed sale of 2,500,000 common shares, with an aggregate market value of $32,650,000 and an approximate sale date of October 15, 2026. Morgan Stanley Smith Barney LLC is listed as broker. ICEVULCAN INVESTMENTS LIMITED also reported selling 1,402,347 common shares on August 19, 2026, for gross proceeds of $22,539,362.39; these sales are identified as 10b5-1 sales.
Key Figures
Key Terms
10b5-1 Sales regulatory
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.